APA (7th ed.) Citation

G, R., GF, S., & S, K. (2010). Persistence on prostaglandin ocular hypotensive therapy: An assessment using medication possession and days covered on therapy. BMC ophthalmology, 10, 5. https://doi.org/10.1186/1471-2415-10-5

Chicago Style (17th ed.) Citation

G, Reardon, Schwartz GF, and Kotak S. "Persistence on Prostaglandin Ocular Hypotensive Therapy: An Assessment Using Medication Possession and Days Covered on Therapy." BMC Ophthalmology 10 (2010): 5. https://doi.org/10.1186/1471-2415-10-5.

MLA (9th ed.) Citation

G, Reardon, et al. "Persistence on Prostaglandin Ocular Hypotensive Therapy: An Assessment Using Medication Possession and Days Covered on Therapy." BMC Ophthalmology, vol. 10, 2010, p. 5, https://doi.org/10.1186/1471-2415-10-5.